QGEN
Qiagen N.V.NYSEHealthcare$41.03+1.61%OpenMarket Cap: $8.46B
As of 2026-04-06
Valuation
P/E (TTM)
19.90
PEG
0.05
P/B
2.26
P/S
4.05
EV/EBITDA
12.93
DCF Value
$67.59
FCF Yield
5.4%
Div Yield
6.5%
Margins & Returns
Gross Margin
61.8%
Operating Margin
24.9%
Net Margin
20.3%
ROE
11.9%
ROA
13.2%
ROIC
7.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $540.4M | 58.7% | $153.9M | $107.8M | $0.52 | — |
| FY 2025 | $2.09B | 61.8% | $520.3M | $424.9M | $2.04 | $1.51 |
| Q3 2025 | $532.6M | 62.2% | $129.2M | $130.0M | $0.60 | $0.25 |
| Q2 2025 | $533.5M | 62.7% | $121.9M | $96.3M | $0.44 | — |
| Q1 2025 | $483.5M | 63.8% | $115.3M | $90.8M | $0.41 | $1.26 |
| Q4 2024 | $521.2M | 63.9% | $119.1M | $88.3M | $0.41 | — |
| FY 2024 | $1.98B | 48.9% | $97.7M | $83.6M | $0.38 | $1.28 |
| Q3 2024 | $501.9M | 61.4% | $112.1M | $98.1M | $0.44 | — |
| Q2 2024 | $496.3M | 7.0% | $-228.4M | $-183.5M | $-0.83 | — |
| Q1 2024 | $458.8M | 63.4% | $94.9M | $80.7M | $0.36 | $1.28 |
| Q4 2023 | $509.2M | 62.1% | $110.6M | $97.7M | $0.44 | — |
| FY 2023 | $1.97B | 62.8% | $409.9M | $341.3M | $1.65 | — |